The German Network for Personalized Medicine to enhance patient care and translational research.
Nat Med
2023
29
6
1298-1301
MULTIOMIC ANALYSIS OF CHIP BONE MARROW HEMATOPOIETIC STEM/PROGENITOR CELLS REVEALS A POTENTIAL EARLY STAGE OF MALIGNANCY
Ann Hematol
2023
102 Suppl 1
SUPPL 1
S18-S19
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.
Clin Cancer Res
2023
29
17
3313-3319
Identification and characterization of KLHL14 as a novel tumor suppressor in in B cell malignancies
Oncology Research and Treatment
2023
46 Suppl 5
236-236
Comparison of the microbiome in saliva and stool in allogeneic stem cell transplanted patients: do salivary signatures predict changes in the gut?
Oncology Research and Treatment
2023
46 Suppl 5
263-264
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
2023
58
6
710-716
Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.
Visc Med
2024
40
4
1-6
PROFILING NEOANTIGEN-SPECIFIC T CELL RECEPTOR ACTIVATION: MODERATE STIMULATION PATTERNS LINKED TO INCREASED T CELL RESILIENCE
Hum Gene Ther
2023
34
21-22
A17-A17
MASS SPECTROMETRY-BASED IMMUNOPEPTIDOMICS APPROACH REVEALS IMMUNOGENICITY OF A POTENTIAL NEOANTIGEN IN THE MULTIPLE MYELOMA CELL LINE JJN3
Hum Gene Ther
2023
34
21-22
A44-A45
Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment : An expert view.
Wien Klin Wochenschr
2024
136
11-12
362-368